"Indap" capsules. Umarnin don amfani

Drug "Indap" - antihypertensive miyagun ƙwayoyi da cewa abubuwa a matsayin vasodilator da diuretic. Saba saki nau'i na da miyagun ƙwayoyi - capsules dauke 2.5 MG indapamide hemihydrate. Medicine "Indap" da aka sanya a rage hawan jini da magani daga hauhawar jini.

Ka'idar mataki da miyagun ƙwayoyi ne kama da thiazide diuretics, wanda mashahuri likitoci, a duniya, dole ne su kasance ba a wani makirci na lura da hauhawar jini. Game da "Indap" shiri umarnin don yin amfani da nuna cewa da aikin dangane da take hakkin reabsorption na sodium ions a cikin farfajiya sashe a cikin madauki na Henle. Game da shi kara tukar tumbi da magnesium, potassium, sodium da kuma chloride tukar tumbi. Da miyagun ƙwayoyi selectively tubalan da "jinkirin" alli tashoshi, rage gefe jijiyoyin bugun gini juriya qara elasticity na katangu.

Tun da shi ba a lura da sakamako daga cikin miyagun ƙwayoyi a metabolism na carbohydrates da lipids a cikin jini jini, shi za a iya sanya wa masu ciwon sukari. Duk da haka, da irin wannan exacerbation na ciwon sukari shi ne ketoacidosis, wani magani "Indap" wa'azi aka lura, kada rubũta.

Abin lura shi ne cewa high dosages na medicament dalili ya karu da fitsari fitarwa, amma mataki na jini ragewan effects ba a bayar. Wannan shi ne dalilin da ya sa magani "Indap" rika yi akai-akai da kuma consistently, wanda zai taimaka wajen rage a matsa lamba, fara daga mako na biyu na cikin shakka.

Drug "Indap". Umarnin don amfani. contraindications

Kamar yadda na bayyane contraindications da amfani, da jerin kwayoyi "Indap" quite m. A musamman, da aiki da miyagun ƙwayoyi ne contraindicated a anuria, hanta lalacewa, hypokalemia, koda cuta, da kuma a cikin hali na rashin ha} uri indapamide. Har ila yau, da miyagun ƙwayoyi ba da shawarar a sanya wani rashin lafiyan dauki ga lactose, glucose malabsorption, tare da galactosemia, a take hakkin cerebral wurare dabam dabam.

Ga wasu cututtuka wajabta da miyagun ƙwayoyi "Indap" na iya zama, idan da barazana da hauhawar jini ga jiki ya wuce hadarin matsalolin da iya zama tare da wasu yiwuwar faruwa a ta liyafar. Yana cututtuka irin ascites, matsakaici koda / hanta insufficiency, cuta na ruwa da kuma electrolyte balance, hyperuricemia, hyponatremia, hyperparathyroidism, urate nefrourolitiaz da gout. Haka ya shafi cikin nono lokaci.

"Indap". Umarnin don amfani. illa

A mataki na tsanani daga gefen effects dogara a kan kashi "Indap" shirye-shiryen. Duk da haka, da inji kutse a cikin tafiyar matakai na rayuwa, halayyar da aiki sashi daga cikin miyagun ƙwayoyi, ya sa aka fadi da kewayon illa a kan daban-daban jiki tsarin. A musamman, akwai da wadannan iri gefen sakamakon wannan magani:

• narkewa (dyspepsia, a cikin filin na gastrointestinal zafi, tashin zuciya, bushe baki, Heart stool, amai, gastralgia, cin cuta) tsarin.
• juyayi tsarin (nervousness, juwa ko jiri, gajiya, ciwon kai, disturbances na vestibular na'ura, drowsiness, ciki, rashin barci, irritability, agitation, juyayi, nervousness, tashin hankali, gajiya, asthenia, lethargy, malaise, gajiya, spasms da tsoka zaruruwa).
• a kan hankula (conjunctivitis, cuta na gani ji).
• miciwa (pharyngitis, rhinitis, tari).
• a kan zuciya da jijiyoyin jini tsarin (arrhythmias, palpitations, orthostatic hypotension, hypokalemia).
• a kan urinary tsarin (nocturia, polyuria, m urinary fili cututtuka).

Akwai kuma wani gefen sakamako "Indap" kwayoyi hada da ciwon baya, kayar da dama ciwon ya kama, mura-kamar bayyanar cututtuka, zafi a cikin sternum, ta ƙara sweating, disturbances na libido da kuma iko, numbness da tingling a cikin extremities, allergies, kwatsam nauyi asara, hyperglycemia, hyponatremia, hyposalemia, hyperuricaemia, glycosuria, da kuma da dama sauran take hakki na tafiyar matakai na rayuwa a cikin jiki.

dosing

Idan sanya miyagun ƙwayoyi "Indap" umurci manual shirya yau da kullum lokaci liyafar da safe hours, ta bakinsa, ba ya ba da damar a sashi ya fi girma saboda kara a cikin wannan harka, yiwuwar faru na illa da kuma inaccessibility na al'ada jini matakan. Lokacin da hauhawar jini yana dauke da farko sashi na 1.25-2.5 MG da rana (ga neprolongirovannogo indapamide siffofin) ko 1.5 MG (for shafe tsawon siffofin indapamide) a kowace rana. Idan tasiri na miyagun ƙwayoyi jiyya bai isa ba, ya kamata a kara da magani regimen bayan 4-8 makonni na magani da sauran sunadaran da mataki.